Items where authors include "Sammons, S.L."

Article

Goetz, M.P., Wander, S.A., Bachelot, T. et al. (8 more authors) (2025) ELAINE 3: phase 3 study of lasofoxifene plus abemaciclib to treat ER+/HER2-, ESR1-mutated, metastatic breast cancer. Future Oncology, 21 (11). pp. 1317-1324. ISSN 1479-6694

Conference abstract

Goetz, M.P., Wander, S.A., Bachelot, T. et al. (17 more authors) (2024) Open-label, randomized, multicenter, phase 3, ELAINE 3 study of the efficacy and safety of lasofoxifene plus abemaciclib for treating ER+/HER2-, locally advanced or metastatic breast cancer with an ESR1 mutation. [Conference abstract]